GLG Partners’s Affimed AFMD Stock Holding History

GLG Partners’s Portfolio AFMD Stock Details AFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-5,940	Closed	-$423K	–	404
2015 Q4	$423K	Sell	5,940 -5,919	-50%	-$402K	0.01%	379
2015 Q3	$732K	Buy	+11,859	New	+$1.47M	0.02%	380

Other funds holding AFMD

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

GLG Partners's AFMD Position: Q1 2016 in Review

GLG Partners sold out of Affimed (AFMD) in Q1 2016, closing a stake of 5,940 shares — an estimated $423K sold.

GLG Partners first reported a position in AFMD in Q3 2015 and held it in 2 quarters. The position peaked at $732K in Q3 2015. 52 funds tracked by Wall St. Rank hold AFMD as of Q1 2016.

GLG Partners reported no remaining Affimed position as of Q1 2016 after selling out during the quarter.
GLG Partners sold 5,940 Affimed shares in Q1 2016, an estimated $423K.
GLG Partners first reported a position in Affimed in Q3 2015 and held it in 2 quarters.
GLG Partners's Affimed position peaked at $732K in Q3 2015.
52 funds tracked by Wall St. Rank held Affimed as of Q1 2016.

Based on GLG Partners's 13F filing for Q1 2016, filed 16 May 2016.